Research Summary
Alpha 1 antitrypsin deficiency is treated with replacement therapy, which involves the infusion of purified alpha 1 antitrypsin protein into the patient's bloodstream. This can help to protect the patient's lungs and liver from further damage caused by the deficiency. Other treatments may include symptom management with bronchodilators, steroids, and antibiotics, as well as lifestyle changes such as stopping smoking and avoiding exposure to lung irritants. In severe cases, lung or liver transplant may be necessary.
According to DIResearch's in-depth investigation and research, the global Alpha 1 Antitrypsin Deficiency Treatment market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Alpha 1 Antitrypsin Deficiency Treatment include Pfizer, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceutical Industries, Takeda, Baxter, Grifols, CSL Behring, Kamada Ltd, Chiesi Pharmaceuticals, Kedrion Group, Vertex Pharmaceuticals, ProMetic Life Sciences etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Alpha 1 Antitrypsin Deficiency Treatment. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Alpha 1 Antitrypsin Deficiency Treatment market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Alpha 1 Antitrypsin Deficiency Treatment market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Alpha 1 Antitrypsin Deficiency Treatment industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Alpha 1 Antitrypsin Deficiency Treatment Include:
Pfizer
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceutical Industries
Takeda
Baxter
Grifols
CSL Behring
Kamada Ltd
Chiesi Pharmaceuticals
Kedrion Group
Vertex Pharmaceuticals
ProMetic Life Sciences
Alpha 1 Antitrypsin Deficiency Treatment Product Segment Include:
Alpha-1 Protease Inhibitor
Bronchodilators
Antioxidants
Other
Alpha 1 Antitrypsin Deficiency Treatment Product Application Include:
COPD
Cystic Fibrosis(CF)
Non-CF Bronchiectasis(NCFB)
Diabetes
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Alpha 1 Antitrypsin Deficiency Treatment Industry PESTEL Analysis
Chapter 3: Global Alpha 1 Antitrypsin Deficiency Treatment Industry Porter's Five Forces Analysis
Chapter 4: Global Alpha 1 Antitrypsin Deficiency Treatment Major Regional Market Size and Forecast Analysis
Chapter 5: Global Alpha 1 Antitrypsin Deficiency Treatment Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Alpha 1 Antitrypsin Deficiency Treatment Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Alpha 1 Antitrypsin Deficiency Treatment Market Overview 1.1 Product Definition and Statistical Scope 1.2 Alpha 1 Antitrypsin Deficiency Treatment Product by Type 1.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Alpha-1 Protease Inhibitor 1.2.3 Bronchodilators 1.2.4 Antioxidants 1.2.5 Other 1.3 Alpha 1 Antitrypsin Deficiency Treatment Product by Application 1.3.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 COPD 1.3.3 Cystic Fibrosis(CF) 1.3.4 Non-CF Bronchiectasis(NCFB) 1.3.5 Diabetes 1.4 Global Alpha 1 Antitrypsin Deficiency Treatment Market Revenue Analysis (2019-2030) 1.5 Alpha 1 Antitrypsin Deficiency Treatment Market Development Status and Trends 1.5.1 Alpha 1 Antitrypsin Deficiency Treatment Industry Development Status Analysis 1.5.2 Alpha 1 Antitrypsin Deficiency Treatment Industry Development Trends Analysis 2 Alpha 1 Antitrypsin Deficiency Treatment Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Alpha 1 Antitrypsin Deficiency Treatment Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Alpha 1 Antitrypsin Deficiency Treatment Market Analysis by Regions 4.1 Alpha 1 Antitrypsin Deficiency Treatment Overall Market: 2023 VS 2024 VS 2030 4.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue and Market Share by Region (2019-2024) 4.2.2 Global Alpha 1 Antitrypsin Deficiency Treatment Revenue Forecast by Region (2025-2030) 5 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type and Application 5.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 5.2 Global Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 6 North America 6.1 North America Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 6.4 North America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 6.5 North America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 7.4 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 7.5 Europe Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 8.4 China Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 9.4 APAC (excl. China) Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 9.5 APAC (excl. China) Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 10.4 Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 10.5 Latin America Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Type 11.4 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Application 11.5 Middle East & Africa Alpha 1 Antitrypsin Deficiency Treatment Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Alpha 1 Antitrypsin Deficiency Treatment Market Revenue by Key Manufacturers (2020-2024) 12.2 Alpha 1 Antitrypsin Deficiency Treatment Competitive Landscape Analysis and Market Dynamic 12.2.1 Alpha 1 Antitrypsin Deficiency Treatment Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Pfizer 13.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.1.3 Pfizer Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 GlaxoSmithKline 13.2.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.2.3 GlaxoSmithKline Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 AstraZeneca 13.3.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.3.3 AstraZeneca Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Boehringer Ingelheim 13.4.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.4.3 Boehringer Ingelheim Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Teva Pharmaceutical Industries 13.5.1 Teva Pharmaceutical Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.5.3 Teva Pharmaceutical Industries Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Takeda 13.6.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Takeda Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.6.3 Takeda Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Baxter 13.7.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Baxter Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.7.3 Baxter Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 Grifols 13.8.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Grifols Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.8.3 Grifols Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 CSL Behring 13.9.1 CSL Behring Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.9.3 CSL Behring Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Kamada Ltd 13.10.1 Kamada Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.10.3 Kamada Ltd Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Chiesi Pharmaceuticals 13.11.1 Chiesi Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.11.3 Chiesi Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Kedrion Group 13.12.1 Kedrion Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.12.3 Kedrion Group Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Vertex Pharmaceuticals 13.13.1 Vertex Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.13.3 Vertex Pharmaceuticals Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 ProMetic Life Sciences 13.14.1 ProMetic Life Sciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Product Portfolio 13.14.3 ProMetic Life Sciences Alpha 1 Antitrypsin Deficiency Treatment Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Alpha 1 Antitrypsin Deficiency Treatment Industry Chain Analysis 14.2 Alpha 1 Antitrypsin Deficiency Treatment Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Alpha 1 Antitrypsin Deficiency Treatment Typical Downstream Customers 14.4 Alpha 1 Antitrypsin Deficiency Treatment Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support